Back to TSHA

RA CAPITAL MANAGEMENT, L.P. → TSHA

RA CAPITAL MANAGEMENT, L.P. TSHA Position History

Taysha Gene Therapies, Inc. • Healthcare

Quarters held
4
Latest value
$148.2M
Q3 2026
Peak value
$160.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$129.6M
Q1 2026$105.3M
Q2 2026$160.4M
Q3 2026$148.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$148.2M30.44M——
Q2 2026$160.4M23.56M——
Q1 2026$105.3M23.56M——
Q4 2025$129.6M23.56M——

Other funds holding TSHA

Other RA CAPITAL MANAGEMENT, L.P. positions

ASND

ASCENDIS PHARMA A/S

$2.7B
ASND

ASCENDIS PHARMA A/S - ADR

$2.4B
ASND

ASCENDIS PHARMA A/S

$2.3B
ASND

ASCENDIS PHARMA A/S - ADR

$2.2B
PBLS

PARABILIS MEDICINES INC

$942.2M
PBLS

PARABILIS MEDICINES INC

$791.9M
RYTM

RHYTHM PHARMACEUTICALS INC

$740.2M
RYTM

RHYTHM PHARMACEUTICALS INC

$713.6M